Trade AbbVie ABBV

AbbVie live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close change Change (%) Open High Low

AbbVie news

Tommy Yap 2025 Apr 19, 16:00

Week Ahead: Growth, Inflation, and Consumer Trends in Focus

Forex Indices
Federal Reserve Rate Decision 
Darius Anucauskas 2025 Jan 25, 16:00

Week Ahead: China Is On Holiday, But The BoC, The Fed, And The ECB Will Be Busy With The First 2025 Rate Announcements 

Forex Indices
Magnificent 7 earnings, US and Japan inflation due next week
Neil Wilson 2024 Jul 18, 16:00

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Forex Indices
Wall Street earnings
Neil Wilson 2023 Oct 20, 10:00

Week ahead: Earnings bonanza, ECB decision & US inflation

Forex Indices
Neil Wilson 2023 Jul 21, 00:09

Week ahead: Fed, ECB & BoJ in action

Forex Indices

Latest news

Show more
Frances Wang 2025 May 06, 16:00

Trending forex pairs: EUR/USD Fluctuates, USD/TWD Drops, AUD/JPY Rises

Forex
Tommy Yap 2025 May 06, 16:00

Morning Note: Fed Rate Decision Awaited; Uber's Report Looms; Oil Recovers Ground

Morning Note Fed Oil USD
Frances Wang 2025 May 05, 16:00

XRP news today: Ripple Launches First-of-Its-Kind $25M RLUSD Fund

Cryptocurrencies
Tommy Yap 2025 May 05, 16:00

Morning Note: Cautious Optimism on US-China Trade; AMD & Arista Reports Loom

Morning Note Tech
Tommy Yap 2025 May 04, 16:00

Morning Note: Palantir's Report in Focus; Stable Swiss CPI; US Services Data Due

Morning Note Tech
an alarm clock with an arrow going up and down
Tommy Yap 2025 May 03, 21:00

Week Ahead: Fed and BoE Interest Rate Announcements in the Spotlight

Forex Indices
Frances Wang 2025 Apr 29, 16:00

Tariff news today: Trump softens car tariffs, Amazon to display tariff costs

Fed
Tommy Yap 2025 Apr 29, 16:00

Morning Note: Aussie CPI Up Slightly; Canada GDP Looms; US PCE Watch

Morning Note AUD CAD

Info

Spread

1.24

Spread (%)

0.6621 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Thursday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

351089459200

Shares Outstanding

1768979968

Earnings Date (Next)

0000-00-00

instr__dividend_date

2025-05-15

instr__ex_dividend_date

2025-04-15

instr__forward_annual_dividend_rate

6.56

instr__forward_annual_dividend_yield

0.0331

EPS

2.34

Learn more about this instrument

AbbVie AbbVie Inc
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Trustpilot